U.S.
Bayer’s $7.25bn Roundup cancer deal wins US court approval
The agreement covers people already ill and those who may develop non-Hodgkin lymphoma later. Payments will be spread over as many as 21 years.
Topic
The agreement covers people already ill and those who may develop non-Hodgkin lymphoma later. Payments will be spread over as many as 21 years.